TY - JOUR
T1 - Prostaglandin E2 selectively antagonizes prostaglandin F 2α-stimulated T-cell factor/β-catenin signaling pathway by the FPB prostanoid receptor
AU - Fujino, Hiromichi
AU - Vielhauer, George A.
AU - Regan, John W.
PY - 2004/10/15
Y1 - 2004/10/15
N2 - FP prostanoid receptors are G-protein-coupled receptors that consist of two isoforms named FPA and FPB. Both isoforms activate inositol phosphate second messenger signaling pathways by their endogenous ligand prostaglandin F2α (PGF2α). Previously we have shown that both isoforms undergo Rho-mediated cell rounding following treatment with PGF2α. Following the removal of PGF 2α, however, FPA-expressing cells return to their original morphology, whereas FPB-expressing cells do not. It was also found that PGF2α-could activate T-cell factor (Tcf)/β-catenin signaling in cells expressing the FPB isoform but not in cells expressing the FPA isoform. We now show that prostaglandin E2 (PGE2) can induce cell rounding and stimulate the formation of inositol phosphates to the same extent as PGF 2α in cells expressing either the FPA or FP B isoforms. However, PGE2 has much lower efficacy as compared with PGF2α for the activation of Tcf/β-catenin signaling in FPB-expressing cells, and the cell rounding is reversible. Interestingly, pretreatment of FPB-expressing cells with PGE2-attenuated PGF2α-stimulated Tcf/β-catenin signaling in a dose-dependent manner while having no effect on PGF 2α-stimulated inositol phosphates formation. Thus, the ratio of endogenous PGE2 and PGF2α has the potential to selectively regulate one signaling pathway over another. This represents a novel mechanism for the regulation of cell signaling that is distinct from regulation occurring at the level of the receptor and its effector pathways.
AB - FP prostanoid receptors are G-protein-coupled receptors that consist of two isoforms named FPA and FPB. Both isoforms activate inositol phosphate second messenger signaling pathways by their endogenous ligand prostaglandin F2α (PGF2α). Previously we have shown that both isoforms undergo Rho-mediated cell rounding following treatment with PGF2α. Following the removal of PGF 2α, however, FPA-expressing cells return to their original morphology, whereas FPB-expressing cells do not. It was also found that PGF2α-could activate T-cell factor (Tcf)/β-catenin signaling in cells expressing the FPB isoform but not in cells expressing the FPA isoform. We now show that prostaglandin E2 (PGE2) can induce cell rounding and stimulate the formation of inositol phosphates to the same extent as PGF 2α in cells expressing either the FPA or FP B isoforms. However, PGE2 has much lower efficacy as compared with PGF2α for the activation of Tcf/β-catenin signaling in FPB-expressing cells, and the cell rounding is reversible. Interestingly, pretreatment of FPB-expressing cells with PGE2-attenuated PGF2α-stimulated Tcf/β-catenin signaling in a dose-dependent manner while having no effect on PGF 2α-stimulated inositol phosphates formation. Thus, the ratio of endogenous PGE2 and PGF2α has the potential to selectively regulate one signaling pathway over another. This represents a novel mechanism for the regulation of cell signaling that is distinct from regulation occurring at the level of the receptor and its effector pathways.
UR - http://www.scopus.com/inward/record.url?scp=6344241868&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=6344241868&partnerID=8YFLogxK
U2 - 10.1074/jbc.M408276200
DO - 10.1074/jbc.M408276200
M3 - Article
C2 - 15280380
AN - SCOPUS:6344241868
SN - 0021-9258
VL - 279
SP - 43386
EP - 43391
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 42
ER -